Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIRT3 | Q9NTG7 | 2/20 | 0.58 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.58 |
| ▸ | CA12 | O43570 | 1/20 | 0.50 |
| ▸ | CA1 | P00915 | 1/20 | 0.50 |
| ▸ | CA2 | P00918 | 1/20 | 0.50 |
| ▸ | CA9 | Q16790 | 1/20 | 0.50 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.50 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | F7 | P08709 | 1/20 | 0.42 |
| ▸ | F3 | P13726 | 1/20 | 0.42 |
| ▸ | SARM1 | Q6SZW1 | 1/20 | 0.42 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.42 |
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 0.42 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.42 |
| ▸ | SIRT5 | Q9NXA8 | 1/20 | 0.42 |
| ▸ | SIRT4 | Q9Y6E7 | 1/20 | 0.42 |
| ▸ | KDM4C | Q9H3R0 | 3/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9142180 | 0.98 | SIRT3 (0.56) | SIRT3TDP1CA12CA1CA2 | |
| Hydrochloric Acid SCHEMBL7084808 | 0.98 | SIRT3 (0.56) | SIRT3TDP1CA12CA1CA2 | |
| Acetone SCHEMBL5667714 | 0.94 | SIRT3 (0.58) | SIRT3TDP1CA12CA1CA2 | |
| SCHEMBL6757557 | 0.88 | SIRT3 (0.58) | SIRT3TDP1IRAK4KDM4EHTT | |
| SCHEMBL3569822 | 0.86 | SIRT3 (0.61) | SIRT3TDP1CA12CA1CA2 | |
| SCHEMBL19611328 | 0.84 | KDM4C (0.55) | SIRT3TDP1CA12CA1CA2 | |
| SCHEMBL188821 | 0.84 | KDM4C (0.55) | SIRT3TDP1CA12CA1CA2 | |
| SCHEMBL4654937 | 0.82 | CA12 (0.49) | SIRT3TDP1CA12CA1CA2 | |
| Cysteine SCHEMBL14333909 | 0.82 | PTGS1 (0.43) | SIRT3TDP1CA12CA1CA2 | |
| SCHEMBL30545160 | 0.80 | SIRT3 (0.54) | SIRT3TDP1IRAK4KDM4EKDM4C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1080 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260077073-A1 | GASTRIN-RELEASING PEPTIDE RECEPTOR (GRPR)-TARGETED COMPOUNDS AND USES THEREOF | ALPHA 9 ONCOLOGY INC (CA) | 2026-03-19 | — | — | US | claimed |
| US-20250346589-A1 | RADIOISOTOPE LABELED SSTR2-AGONISTS WITH LINKERS | UNIV ERASMUS MED CT ROTTERDAM (NL) | 2025-11-13 | — | — | US | claimed |
| US-20250295821-A1 | TARGETED RADIOPHARMACEUTICAL FOR TUMOR AND ITS USE IN THE IMAGING-GUIDED COMBINATION THERAPY OF TARGETED RADIOTHERAPY AND IMMUNOTHERAPY | BeijingGiluntidePharmaceuticalCo.,Ltd. (CN) | 2025-09-25 | — | — | US | claimed |
| WO-2025147774-A1 | COMPOSITIONS TARGETING BRADYKININ RECEPTOR B1 FOR MEDICAL IMAGING AND TREATMENT OF CANCER AND OTHER DISORDERS | ALPHA-9 ONCOLOGY INC. (CA) | 2025-07-17 | — | — | WO | claimed |
| WO-2025125621-A1 | CANCER-ASSOCIATED PROTEIN-TARGETED STRONG OR COVALENTLY BINDING PRECURSOR COMPOUNDS AND RADIOTRACERS | RADIOVAXX GMBH (DE) | 2025-06-19 | — | — | WO | claimed |
| US-20250195702-A1 | RADIOLABELED COMPOUNDS FOR IN VIVO IMAGING OF GASTRIN-RELEASING PEPTIDE RECEPTOR (GRPR) AND TREATMENT OF GRPR-RELATED DISORDERS | PROVINCIAL HEALTH SERVICES AUTHORITY (CA) | 2025-06-19 | — | — | US | claimed |
| CN-116370660-B | PECAM-1 targeting diagnosis and treatment integrated nano-probe and preparation method and application thereof | 华中科技大学同济医学院附属协和医院 | 2025-05-30 | — | — | CN | claimed |
| US-20250161501-A1 | Radiolabeled Compounds for Imaging of Fibroblast Activation Protein (FAP) and Treatment of FAP-Related Disorders | PROVINCIAL HEALTH SERVICES AUTHORITY (CA) | 2025-05-22 | — | — | US | claimed |
| EP-4529474-A1 | RADIOISOTOPE LABELED SSTR2-AGONISTS WITH LINKERS | Erasmus University Rotterdam Medical Center (NL) | 2025-04-02 | — | — | EP | claimed |
| EP-3965885-B1 | METHODS AND COMPOSITIONS FOR REVERSING PLATELET CLUMPING | TRUVIAN SCIENCES INC (US) | 2025-03-26 | — | — | EP | claimed |
| EP-1208116-A2 | SOMATOSTATIN ANALOGS, RADIOLABELLED DERIVATIVES THEREOF AND THEIR USE | SCHERING AKTIENGESELLSCHAFT (DE) | 2002-05-29 | — | — | EP | claimed |
| US-6358491-B1 | FOR CANCER IMAGING AND THERAPY USING NOVEL SOMATOSTATIN ANALOGS, MEDICAL DIAGNOSIS, RADIOPHARMACEUTICALS | BERLEX LABORATORIES, INC. | 2002-03-19 | — | — | US | claimed |
| CN-1077439-C | Labeled chemotactic peptides for imaging of sites of infection or inflammation lesions | GEN HOSPITAL CORP (US) | 2002-01-09 | — | — | CN | claimed |
| WO-2001060863-A1 | RADIOLABELED VASOACTIVE INTESTINAL PEPTIDE ANALOGS FOR DIAGNOSIS AND RADIOTHERAPY | DABUR RESEARCH FOUNDATION (IN) | 2001-08-23 | — | — | WO | claimed |
| WO-2001044177-A2 | SOMATOSTATIN ANALOGS, RADIOLABELLED DERIVATIVES THEREOF AND THEIR USE | SCHERING AKTIENGESELLSCHAFT (DE) | 2001-06-21 | — | — | WO | claimed |
| US-6197278-B1 | IMAGING APOPTOSIS BY ADMINISTERING TO THE PATIENT, ANNEXIN LABELED WITH A RADIONUCLIDE, MEASURING RADIATION EMISSION FROM RADIONUCLIDE WITH RADIO DETECTOR TO CONSTUCT AN IMAGE OF RADIATION EMISSION WHICH REPRESENT CELL DEATH OF THE MAMMAL | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | 2001-03-06 | — | — | US | claimed |
| CN-1265572-A | Method for imaging cell death in vivo | UNIV LELAND STANFORD JUNIOR (US) | 2000-09-06 | — | — | CN | claimed |
| EP-1017318-A1 | METHOD OF IMAGING CELL DEATH IN VIVO | THE BOARD OF DIRECTORS OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2000-07-12 | — | — | EP | claimed |
| WO-1998048699-A1 | METHOD OF IMAGING CELL DEATH IN VIVO | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 1998-11-05 | — | — | WO | claimed |
| WO-1994028943-A1 | ANALOGS OF CYTOCHALASIN B AS RADIOPHARMACEUTICALS FOR NUCLEAR IMAGING OF TRANS-MEMBRANE GLUCOSE TRANSPORT | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1994-12-22 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250346589-A1 | RADIOISOTOPE LABELED SSTR2-AGONISTS WITH LINKERS | SSTR2, SSTR5, SSTR1 | SIRT3 1762/4885TDP1 4134/4885CA12 291/4885 |
| US-20250295821-A1 | TARGETED RADIOPHARMACEUTICAL FOR TUMOR AND ITS USE IN THE IMAGING-GUIDED COMBINATION THERAPY OF TARGETED RADIOTHERAPY AND IMMUNOTHERAPY | CD274, ITGB1, ITGA1 | SIRT3 1651/4885TDP1 2018/4885CA12 1222/4885 |
| US-20250161501-A1 | Radiolabeled Compounds for Imaging of Fibroblast Activation Protein (FAP) and Treatment of FAP-Related Disorders | FAP, FIBP, FGFR1 | SIRT3 3619/4885TDP1 2737/4885CA12 1026/4885 |
| US-20250195702-A1 | RADIOLABELED COMPOUNDS FOR IN VIVO IMAGING OF GASTRIN-RELEASING PEPTIDE RECEPTOR (GRPR) AND TREATMENT OF GRPR-RELATED DISORDERS | GRPR, NPY5R, NPY2R | SIRT3 2574/4885TDP1 923/4885CA12 930/4885 |
| US-20260077073-A1 | GASTRIN-RELEASING PEPTIDE RECEPTOR (GRPR)-TARGETED COMPOUNDS AND USES THEREOF | GRPR, GIPR, GLP1R | SIRT3 4186/4885TDP1 1563/4885CA12 663/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.